Nuwellis, Inc. (NUWE) stock
NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/3082% below fair value
$4.90−0.13 (-2.58%)
Close on Nov 13, 2026Market cap $2.65MP/E –Yield –
Nuwellis total assets
Total assets on the balance sheet at the end of each period.
Nuwellis's total assets was $13.45M at Sep 30, 2026. For fiscal 2025 it was $6.12M, down 38.0% from the year before. Over ten years it grew -12.9% a year on average. The highest annual figure on record is $55.23M in fiscal 2013.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.12M | -38.0% |
| FY2024 | Dec 31, 2024 | $9.86M | +1.0% |
| FY2023 | Dec 31, 2023 | $9.77M | -60.4% |
| FY2022 | Dec 31, 2022 | $24.67M | -18.9% |
| FY2021 | Dec 31, 2021 | $30.42M | +52.0% |
| FY2020 | Dec 31, 2020 | $20.01M | +257.2% |
| FY2019 | Dec 31, 2019 | $5.60M | -36.2% |
| FY2018 | Dec 31, 2018 | $8.78M | -52.4% |
| FY2017 | Dec 31, 2017 | $18.46M | +147.0% |
| FY2016 | Dec 31, 2016 | $7.47M | -69.4% |
| FY2015 | Dec 31, 2015 | $24.45M | -24.5% |
| FY2014 | Dec 31, 2014 | $32.37M | -41.4% |
| FY2013 | Dec 31, 2013 | $55.23M | +267.3% |
| FY2012 | Dec 31, 2012 | $15.04M | +102.3% |
| FY2011 | Dec 31, 2011 | $7.43M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $13.45M | +68.4% |
| Q2 FY2026 | Jun 30, 2026 | $9.13M | -0.8% |
| Q1 FY2026 | Mar 31, 2026 | $6.96M | -0.6% |
| Q4 FY2025 | Dec 31, 2025 | $6.12M | -38.0% |
| Q3 FY2025 | Sep 30, 2025 | $7.98M | +18.7% |
| Q2 FY2025 | Jun 30, 2025 | $9.20M | +48.7% |
| Q1 FY2025 | Mar 31, 2025 | $7.01M | +5.2% |
| Q4 FY2024 | Dec 31, 2024 | $9.86M | +1.0% |
| Q3 FY2024 | Sep 30, 2024 | $6.73M | -41.1% |
| Q2 FY2024 | Jun 30, 2024 | $6.19M | -60.2% |
| Q1 FY2024 | Mar 31, 2024 | $6.66M | -63.9% |
| Q4 FY2023 | Dec 31, 2023 | $9.77M | -60.4% |
| Q3 FY2023 | Sep 30, 2023 | $11.43M | -38.0% |
| Q2 FY2023 | Jun 30, 2023 | $15.55M | -29.3% |
| Q1 FY2023 | Mar 31, 2023 | $18.48M | -29.2% |
| Q4 FY2022 | Dec 31, 2022 | $24.67M | -18.9% |
| Q3 FY2022 | Sep 30, 2022 | $18.44M | -45.9% |
| Q2 FY2022 | Jun 30, 2022 | $22.00M | -25.8% |
| Q1 FY2022 | Mar 31, 2022 | $26.11M | -22.2% |
| Q4 FY2021 | Dec 31, 2021 | $30.42M | +52.0% |
| Q3 FY2021 | Sep 30, 2021 | $34.10M | +43.7% |
| Q2 FY2021 | Jun 30, 2021 | $29.64M | +125.5% |
| Q1 FY2021 | Mar 31, 2021 | $33.56M | +234.1% |
| Q4 FY2020 | Dec 31, 2020 | $20.01M | +257.2% |
| Q3 FY2020 | Sep 30, 2020 | $23.72M | +212.8% |
| Q2 FY2020 | Jun 30, 2020 | $13.14M | +15.0% |
| Q1 FY2020 | Mar 31, 2020 | $10.05M | -34.6% |
| Q4 FY2019 | Dec 31, 2019 | $5.60M | -36.2% |
| Q3 FY2019 | Sep 30, 2019 | $7.58M | -35.7% |
| Q2 FY2019 | Jun 30, 2019 | $11.43M | +4.5% |
| Q1 FY2019 | Mar 31, 2019 | $15.36M | +6.6% |
| Q4 FY2018 | Dec 31, 2018 | $8.78M | -52.4% |
| Q3 FY2018 | Sep 30, 2018 | $11.79M | +26.2% |
| Q2 FY2018 | Jun 30, 2018 | $10.94M | -7.3% |
| Q1 FY2018 | Mar 31, 2018 | $14.41M | +84.2% |
| Q4 FY2017 | Dec 31, 2017 | $18.46M | +147.0% |
| Q3 FY2017 | Sep 30, 2017 | $9.34M | – |
| Q2 FY2017 | Jun 30, 2017 | $11.81M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.82M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.47M | – |
See a number that looks wrong?